ClinicalTrials.govpublic full text
Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
non 24 hour sleep wake disorder, blindness, eye diseases, nap disorders, circadian rhythm disorders, sleep disorders, circadian rhythm sleep disorders, dyssomnias, nervous system diseases, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807447
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.